{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:16:51Z","timestamp":1788257811266,"version":"build-2803163510"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Emerging and re-emerging infections expose a persistent mismatch between the speed of pathogen evolution and the pace of therapeutic development. Conventional two-dimensional cultures are scalable but poorly reproduce tissue architecture, whereas animal models may not capture human-specific tropism, immunity, pharmacokinetics, or toxicity. Human organoids and organ-on-chip systems offer complementary solutions by combining organ-specific human cells with three-dimensional architecture, barrier function, perfusion, mechanical forces, and, increasingly, immune and microbial components. This review evaluates their use in antiviral, antibacterial, antiparasitic, and antifungal pharmacology, with emphasis on drug repurposing, host-directed therapy, RNA and nanomedicine approaches, pharmacokinetic-pharmacodynamic assessment, and tissue-specific safety. We further examine how artificial intelligence, high-content imaging, multi-omics, and computational screening can convert these models into iterative discovery platforms that prioritize targets, compounds, combinations, and biomarkers. Current limitations include incomplete immune and vascular complexity, developmental immaturity, matrix and protocol variability, high cost, biosafety constraints, and limited prospective clinical validation. We propose a pandemic-ready pipeline in which pathogen sequencing and AI-based prioritization are followed by organoid and chip validation, mechanistic omics, multi-organ exposure and toxicity testing, and biomarker-guided clinical translation. Used as complementary rather than universal replacement models, these technologies could reduce false-positive leads, improve dose relevance, and accelerate development of therapeutics that control pathogens while preserving human tissue function.<\/jats:p>","DOI":"10.3389\/fphar.2026.1927806","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:49:46Z","timestamp":1788256186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Human organoids and organ-on-chip systems for AI-guided therapeutic discovery against emerging and re-emerging infections"],"prefix":"10.3389","volume":"17","author":[{"given":"Sarbjeet Kaur","family":"Makkar","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan","place":["Ann Arbor, MI, United States"]},{"name":"Rogel Cancer Center, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan","place":["Ann Arbor, MI, United States"]},{"name":"Rogel Cancer Center, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhi","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan","place":["Ann Arbor, MI, United States"]},{"name":"Rogel Cancer Center, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1039\/D0CS01118E","article-title":"Antiviral drug discovery: preparing for the next pandemic","volume":"50","author":"Adamson","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41467-019-13896-7","article-title":"Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms","volume":"11","author":"Ahn","year":"2020","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","article-title":"Synthetic alternatives to matrigel","volume":"5","author":"Aisenbrey","year":"2020","journal-title":"Nat. Rev. Mater"},{"key":"B5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41564-024-01645-6","article-title":"Organ-on-chip models for infectious disease research","volume":"9","author":"Alonso-Roman","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1038\/s41467-024-48864-3","article-title":"Roadblocks confronting widespread dissemination and deployment of organs on chips","volume":"15","author":"Alver","year":"2024","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0011559","DOI":"10.1371\/journal.pntd.0011559","article-title":"Induced pluripotent stem cell-derived human macrophages as an infection model for Leishmania donovani","volume":"18","author":"Baert","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41577-019-0248-y","article-title":"Organoids in immunological research","volume":"20","author":"Bar-Ephraim","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrmicro2423","article-title":"Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions","volume":"8","author":"Barrila","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1038\/s41467-021-25729-7","article-title":"A CRISPR\/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses","volume":"12","author":"Beumer","year":"2021","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-med-042320-023055","article-title":"Organoid models for infectious disease","volume":"73","author":"Blutt","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.3390\/v14122799","article-title":"Application of a human blood brain barrier organ-on-a-chip model to evaluate small molecule effectiveness against Venezuelan equine encephalitis virus","volume":"14","author":"Boghdeh","year":"2022","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"B20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nmeth.4397","article-title":"Data-analysis strategies for image-based cell profiling","volume":"14","author":"Caicedo","year":"2017","journal-title":"Nat. Methods"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","article-title":"Engineering of human brain organoids with a functional vascular-like system","volume":"16","author":"Cakir","year":"2019","journal-title":"Nat. Methods"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1184362","DOI":"10.3389\/fimmu.2023.1184362","article-title":"Correlation between pseudotyped virus and authentic virus neutralisation assays: a systematic review and meta-analysis","volume":"14","author":"Cantoni","year":"2023","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-04788-w","article-title":"Climate change increases cross-species viral transmission risk","volume":"607","author":"Carlson","year":"2022","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E7118","DOI":"10.1073\/pnas.1521644112","article-title":"Human genetic basis of interindividual variability in the course of infection","volume":"112","author":"Casanova","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41573-020-00117-w","article-title":"Image-based profiling for drug discovery: due for a machine-learning upgrade?","volume":"20","author":"Chandrasekaran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8781","DOI":"10.1038\/s41598-024-59405-9","article-title":"SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids","volume":"14","author":"Chau","year":"2024","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1006677","DOI":"10.1371\/journal.pcbi.1006677","article-title":"Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment","volume":"14","author":"Cokol","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-Targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2020.10.030","article-title":"Identification of required host factors for SARS-CoV-2 infection in human cells","volume":"184","author":"Daniloski","year":"2021","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e60747","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"De Crignis","year":"2021","journal-title":"eLife"},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41579-022-00777-y","article-title":"Anti-trypanosomatid drug discovery: progress and challenges","volume":"21","author":"De Rycker","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"025012","DOI":"10.1088\/1758-5090\/ab7073","article-title":"Co-infection with Staphylococcus aureus after primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-chip model","volume":"12","author":"Deinhardt-Emmer","year":"2020","journal-title":"Biofabrication"},{"key":"B35","doi-asserted-by":"publisher","first-page":"344ra84","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nri3532","article-title":"Autophagy in infection, inflammation and immunity","volume":"13","author":"Deretic","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e00057","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay. Drug Dev. Technol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"841447","DOI":"10.3389\/fcimb.2022.841447","article-title":"Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus","volume":"12","author":"Ekanger","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","article-title":"Performance assessment and economic analysis of a human liver-chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e00159","DOI":"10.1128\/mBio.00159-12","article-title":"Stem cell-derived human intestinal organoids as an infection model for rotaviruses","volume":"3","author":"Finkbeiner","year":"2012","journal-title":"mBio"},{"key":"B45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1128\/IAI.00161-15","article-title":"Interaction of Salmonella enterica serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells","volume":"83","author":"Forbester","year":"2015","journal-title":"Infect. Immun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.drudis.2019.06.003","article-title":"Impact of organ-on-a-chip technology on pharmaceutical R&D costs","volume":"24","author":"Franzen","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.aaf6116","article-title":"Zika virus impairs growth in human neurospheres and brain organoids","volume":"352","author":"Garcez","year":"2016","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"a028902","DOI":"10.1101\/cshperspect.a028902","article-title":"What is the predictive value of animal models for vaccine efficacy in humans? The importance of bridging studies and species-independent correlates of protection","volume":"10","author":"Golding","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.chom.2019.08.007","article-title":"Bioengineered human organ-on-chip reveals intestinal microenvironment and mechanical forces impacting shigella infection","volume":"26","author":"Grassart","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fimmu.2013.00098","article-title":"Modeling the Mycobacterium tuberculosis granuloma: the critical battlefield in host immunity and disease","volume":"4","author":"Guirado","year":"2013","journal-title":"Front. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1126\/science.abb9332","article-title":"Rapid repurposing of drugs for COVID-19","volume":"368","author":"Guy","year":"2020","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e2025581118","DOI":"10.1073\/pnas.2025581118","article-title":"Network medicine framework for identifying drug-repurposing opportunities for COVID-19","volume":"118","author":"Gysi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","article-title":"Identification of SARS-CoV-2 inhibitors using lung and colonic organoids","volume":"589","author":"Han","year":"2021","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B59","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41551-019-0498-9","article-title":"Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips","volume":"4","author":"Herland","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"B60","doi-asserted-by":"publisher","first-page":"121420","DOI":"10.1016\/j.biomaterials.2022.121420","article-title":"Invasive aspergillosis-on-chip: a quantitative treatment study of human Aspergillus fumigatus infection","volume":"283","author":"Hoang","year":"2022","journal-title":"Biomaterials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41592-019-0325-y","article-title":"Flow-enhanced vascularization and maturation of kidney organoids in vitro","volume":"16","author":"Homan","year":"2019","journal-title":"Nat. Methods"},{"key":"B63","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater"},{"key":"B65","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/17512433.2019.1621161","article-title":"Antibiotic exposure at the site of infection: principles and assessment of tissue penetration","volume":"12","author":"Jager","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41551-019-0397-0","article-title":"A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip","volume":"3","author":"Jalili-Firoozinezhad","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"B70","doi-asserted-by":"publisher","first-page":"a029132","DOI":"10.1101\/cshperspect.a029132","article-title":"What is the predictive value of animal models for vaccine efficacy in humans? Reevaluating the potential of mouse models for the human immune system","volume":"10","author":"Jameson","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.12.010","article-title":"SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids","volume":"29","author":"Jansen","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","author":"Johansen","year":"2020","journal-title":"Mucosal Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/mi8010027","article-title":"Human liver sinusoid on a chip for hepatitis B virus replication study","volume":"8","author":"Kang","year":"2017","journal-title":"Micromachines"},{"key":"B75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40580-021-00270-x","article-title":"Organ-on-a-chip technology for nanoparticle research","volume":"8","author":"Kang","year":"2021","journal-title":"Nano Converg."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e53657","DOI":"10.1371\/journal.pone.0053657","article-title":"Human granuloma in vitro model, for TB dormancy and resuscitation","volume":"8","author":"Kapoor","year":"2013","journal-title":"PLoS ONE"},{"key":"B77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.stem.2023.09.001","article-title":"Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19","volume":"30","author":"Kawakami","year":"2023","journal-title":"Cell Stem Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1039\/c2lc40074j","article-title":"Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow","volume":"12","author":"Kim","year":"2012","journal-title":"Lab. Chip"},{"key":"B80","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1073\/pnas.1522193112","article-title":"Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip","volume":"113","author":"Kim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B81","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e00179","DOI":"10.1128\/cmr.00179-21","article-title":"Machine learning for antimicrobial resistance prediction: current practice, limitations, and clinical perspective","volume":"35","author":"Kim","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B84","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2018.00006","article-title":"Three-dimensional in vitro cell culture models in drug discovery and drug repositioning","volume":"9","author":"Langhans","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/IAI.02561-14","article-title":"Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function","volume":"83","author":"Leslie","year":"2015","journal-title":"Infect. Immun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat. Rev. Methods Prim."},{"key":"B90","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"B91","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s44222-023-00063-3","article-title":"Human disease models in drug development","volume":"1","author":"Loewa","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"B93","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s12276-021-00641-8","article-title":"Organoids in image-based phenotypic chemical screens","volume":"53","author":"Lukonin","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-based virtual screening: from classical to artificial intelligence","volume":"8","author":"Maia","year":"2020","journal-title":"Front. Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19: COV-BARRIER","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e3001845","DOI":"10.1371\/journal.pbio.3001845","article-title":"SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with sofosbuvir","volume":"20","author":"Mesci","year":"2022","journal-title":"PLoS Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a for treatment of SARS-CoV-2 infection","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e1003467","DOI":"10.1371\/journal.ppat.1003467","article-title":"Emerging infectious diseases: threats to human health and global stability","volume":"9","author":"Morens","year":"2013","journal-title":"PLoS Pathog."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41467-024-45999-1","article-title":"Learning representations for image-based profiling of perturbations","volume":"15","author":"Moshkov","year":"2024","journal-title":"Nat. Commun."},{"key":"B102","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dki079","article-title":"Standardization of pharmacokinetic\/pharmacodynamic terminology for anti-infective drugs: an update","volume":"55","author":"Mouton","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B103","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Mu\u00f1oz-Fontela","year":"2020","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"B105","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B106","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12936-024-05202-8","article-title":"Human liver organoids are susceptible to Plasmodium vivax infection","volume":"23","author":"Nitaramorn","year":"2024","journal-title":"Malar. J."},{"key":"B107","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41467-018-02969-8","article-title":"3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection","volume":"9","author":"Ortega-Prieto","year":"2018","journal-title":"Nat. Commun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B111","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"B112","doi-asserted-by":"publisher","first-page":"104813","DOI":"10.1016\/j.isci.2022.104813","article-title":"A microengineered brain-chip to model neuroinflammation in humans","volume":"25","author":"Pediaditakis","year":"2022","journal-title":"iScience"},{"key":"B113","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/s41596-021-00589-z","article-title":"Intestinal organoid cocultures with microbes","volume":"16","author":"Puschhof","year":"2021","journal-title":"Nat. Protoc."},{"key":"B115","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","article-title":"A microfluidic platform integrating functional vascularized organoids-on-chip","volume":"15","author":"Quintard","year":"2024","journal-title":"Nat. Commun."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0351121","DOI":"10.1128\/mBio.03511-21","article-title":"The human nose organoid respiratory virus model","volume":"13","author":"Rajan","year":"2022","journal-title":"mBio"},{"key":"B118","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches","volume":"4","author":"Roemer","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41551-022-00882-6","article-title":"A multi-organ chip with matured tissue niches linked by vascular flow","volume":"6","author":"Ronaldson-Bouchard","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e100300","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"key":"B123","doi-asserted-by":"publisher","first-page":"55559","DOI":"10.3791\/55559","article-title":"An in vitro caseum binding assay that predicts drug penetration in tuberculosis lesions","volume":"123","author":"Sarathy","year":"2017","journal-title":"J. Vis. Exp."},{"key":"B124","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B126","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B127","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41551-021-00718-9","article-title":"A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics","volume":"5","author":"Si","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"B128","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B129","doi-asserted-by":"publisher","first-page":"121632","DOI":"10.1016\/j.biomaterials.2022.121632","article-title":"Human macrophage polarization determines bacterial persistence of Staphylococcus aureus in a liver-on-chip-based infection model","volume":"287","author":"Siwczak","year":"2022","journal-title":"Biomaterials"},{"key":"B130","doi-asserted-by":"publisher","first-page":"709856","DOI":"10.3389\/fphar.2021.709856","article-title":"Expert-augmented computational drug repurposing identified baricitinib as a treatment for COVID-19","volume":"12","author":"Smith","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"key":"B132","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"B133","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"key":"B135","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41556-023-01095-y","article-title":"A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection","volume":"25","author":"Tang","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles \u2014 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e59961","DOI":"10.7554\/eLife.59961","article-title":"A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth","volume":"9","author":"Thacker","year":"2020","journal-title":"eLife"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S1473-3099(18)30513-9","article-title":"Analysis of the clinical antibacterial and antituberculosis pipeline","volume":"19","author":"Theuretzbacher","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B139","volume-title":"Roadmap to Reducing Animal Testing in Preclinical Safety Studies","year":"2025"},{"key":"B140","volume-title":"General Considerations for the Use of New Approach Methodologies in Drug Development: Draft Guidance for Industry","year":"2026"},{"key":"B141","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","article-title":"Can animal models of disease reliably inform human studies?","volume":"7","author":"van der Worp","year":"2010","journal-title":"PLoS Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"B144","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","article-title":"Accelerating antiviral drug discovery: lessons from COVID-19","volume":"22","author":"von Delft","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"B145","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","article-title":"Modeling human adaptive immune responses with tonsil organoids","volume":"27","author":"Wagar","year":"2021","journal-title":"Nat. Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B147","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12987-018-0108-3","article-title":"A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport","volume":"15","author":"Wevers","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"B148","doi-asserted-by":"publisher","first-page":"837460","DOI":"10.3389\/fitd.2022.837460","article-title":"Tackling drug resistance and other causes of treatment failure in leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front. Trop. Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","article-title":"Human blood vessel organoids as a model of diabetic vasculopathy","volume":"565","author":"Wimmer","year":"2019","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1039\/C7NP00019G","article-title":"Opportunities for natural products in 21st century antibiotic discovery","volume":"34","author":"Wright","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"B151","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1038\/s41467-023-40298-7","article-title":"Development of Plasmodium falciparum liver stages in hepatocytes derived from human fetal liver organoid cultures","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"B152","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41419-018-0763-y","article-title":"Differential antiviral immunity to Japanese encephalitis virus in developing cortical organoids","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B154","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s44222-024-00207-z","article-title":"Integrating organoids and organ-on-a-chip devices","volume":"2","author":"Zhao","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-directed therapies for infectious diseases: current status, recent progress, and future prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1927806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:49:47Z","timestamp":1788256187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1927806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":155,"alternative-id":["10.3389\/fphar.2026.1927806"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1927806","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1927806"}}